
Description The Sub-Fund will invest principally in securities issued by companies listed on Recognised Exchanges in Hong Kong, the People’s Republic of China, Singapore, the United States and the United Kingdom principally engaged in pharmaceutical, bio-technology, medical devices, healthcare providers and ownership or management of hospitals/nursing homes, health maintenance organizations in the People’s Republic of China. To view the detailed information, you need to SUBSCRIBE with us. |
![]() |